Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Invesco S&P 500 Revenue ETF
RWL
|
+$658M |
| 2 |
Tesla
TSLA
|
+$573M |
| 3 |
Bank of America
BAC
|
+$480M |
| 4 |
Amazon
AMZN
|
+$448M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$445M |
Top Sells
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$493M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$395M |
| 3 |
Eli Lilly
LLY
|
+$364M |
| 4 |
CME Group
CME
|
+$316M |
| 5 |
T-Mobile US
TMUS
|
+$310M |
Sector Composition
| 1 | Technology | 23.42% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.27% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Invesco Value Municipal Income Trust
IIM
$585M
| $407K | ﹤0.01% |
34,023
-32,489
| -49% | -$389K |
|
3152
Spyre Therapeutics
SYRE
$978M
| $407K | ﹤0.01% |
25,207
+5,544
| +28% | +$89.5K |
|
3153
Altimmune
ALT
$326M
| $406K | ﹤0.01% |
81,128
-165,958
| -67% | -$830K |
|
3154
Genie Energy
GNE
$407M
| $406K | ﹤0.01% |
26,948
-3,811
| -12% | -$57.4K |
|
|
NML
3155
Neuberger Berman Energy Infrastructure and Income Fund
NML
$492M
| $405K | ﹤0.01% |
44,981
+13,347
| +42% | +$120K |
|
3156
Ironwood Pharmaceuticals
IRWD
$201M
| $405K | ﹤0.01% |
275,253
-246,735
| -47% | -$363K |
|
|
NVRO
3157
DELISTED
NEVRO CORP.
NVRO
| $403K | ﹤0.01% |
68,954
+16,110
| +30% | +$94.1K |
|
|
NXDR
3158
Nextdoor Holdings
NXDR
$794M
| $400K | ﹤0.01% |
261,660
+18,265
| +8% | +$27.9K |
|
|
AFB
3159
AllianceBernstein National Municipal Income Fund
AFB
$310M
| $399K | ﹤0.01% |
36,714
+920
| +3% | +$9.99K |
|
3160
AnaptysBio
ANAB
$649M
| $397K | ﹤0.01% |
21,336
-1,952
| -8% | -$36.3K |
|
3161
Alta Equipment Group
ALTG
$242M
| $396K | ﹤0.01% |
84,363
+5,781
| +7% | +$27.1K |
|
3162
HBT Financial
HBT
$818M
| $395K | ﹤0.01% |
17,624
-2,808
| -14% | -$62.9K |
|
|
LSEA
3163
DELISTED
Landsea Homes
LSEA
| $394K | ﹤0.01% |
61,354
-13,376
| -18% | -$85.9K |
|
3164
Reservoir Media
RSVR
$524M
| $394K | ﹤0.01% |
51,601
-290
| -0.6% | -$2.21K |
|
3165
indie Semiconductor
INDI
$774M
| $390K | ﹤0.01% |
191,717
+98,389
| +105% | +$200K |
|
|
VERV
3166
DELISTED
Verve Therapeutics
VERV
| $390K | ﹤0.01% |
85,360
+28,220
| +49% | +$129K |
|
|
AVDL
3167
Avadel Pharmaceuticals
AVDL
$1.54B
| $389K | ﹤0.01% |
49,674
-2,468
| -5% | -$19.3K |
|
3168
Accuray
ARAY
$179M
| $388K | ﹤0.01% |
216,547
-9,230
| -4% | -$16.5K |
|
3169
dLocal
DLO
$4B
| $387K | ﹤0.01% |
46,374
-7,356
| -14% | -$61.3K |
|
3170
Alto Ingredients
ALTO
$89.8M
| $385K | ﹤0.01% |
337,461
-101,065
| -23% | -$115K |
|
3171
Anika Therapeutics
ANIK
$124M
| $385K | ﹤0.01% |
25,587
-1,890
| -7% | -$28.4K |
|
|
RFI
3172
Cohen & Steers Total Return Realty Fund
RFI
$321M
| $384K | ﹤0.01% |
31,783
+4,655
| +17% | +$56.3K |
|
3173
Evolus
EOLS
$486M
| $384K | ﹤0.01% |
31,900
+13,574
| +74% | +$163K |
|
3174
Franklin Covey
FC
$246M
| $383K | ﹤0.01% |
13,878
+1,439
| +12% | +$39.7K |
|
3175
FS Bancorp
FSBW
$321M
| $383K | ﹤0.01% |
10,071
-1,208
| -11% | -$45.9K |
|